Lymphangioleiomyomatosis: current and future.

PubWeight™: 1.10‹?› | Rank: Top 10%

🔗 View Article (PMC 3548000)

Published in J Thorac Dis on February 01, 2013

Authors

Maria Mavroudi1, Paul Zarogoulidis, Nikolaos Katsikogiannis, Kosmas Tsakiridis, Haidong Huang, Antonios Sakkas, Anastasios Kallianos, Aggeliki Rapti, Eirini Sarika, Ilias Karapantzos, Konstantinos Zarogoulidis

Author Affiliations

1: Pulmonary Department, "G. Papanikolaou" General Hospital, Aristotle University of Thessaloniki, Thessaloniki, Greece;

Articles cited by this

Sirolimus for angiomyolipoma in tuberous sclerosis complex or lymphangioleiomyomatosis. N Engl J Med (2008) 9.64

Efficacy and safety of sirolimus in lymphangioleiomyomatosis. N Engl J Med (2011) 6.74

Lymphangioleiomyomatosis. Eur Respir J (2006) 4.33

Lymphangioleiomyomatosis: a clinical update. Chest (2008) 3.79

Renal angiomyolipomata. Kidney Int (2004) 3.05

Pulmonary lymphangioleiomyomatosis in a karyotypically normal man without tuberous sclerosis complex. Am J Respir Crit Care Med (2007) 2.94

European Respiratory Society guidelines for the diagnosis and management of lymphangioleiomyomatosis. Eur Respir J (2010) 2.86

Changes in lung function and chylous effusions in patients with lymphangioleiomyomatosis treated with sirolimus. Ann Intern Med (2011) 2.67

Estradiol and tamoxifen stimulate LAM-associated angiomyolipoma cell growth and activate both genomic and nongenomic signaling pathways. Am J Physiol Lung Cell Mol Physiol (2003) 2.54

Diffuse cystic lung disease at high-resolution CT. AJR Am J Roentgenol (2011) 2.31

Decline in lung function in patients with lymphangioleiomyomatosis treated with or without progesterone. Chest (2004) 2.27

Sirolimus therapy for angiomyolipoma in tuberous sclerosis and sporadic lymphangioleiomyomatosis: a phase 2 trial. Clin Cancer Res (2011) 2.06

Lymphangioleiomyomatosis: A review. Eur J Intern Med (2007) 1.80

Estrogen promotes the survival and pulmonary metastasis of tuberin-null cells. Proc Natl Acad Sci U S A (2009) 1.75

Lymphangioleiomyomatosis: what do we know and what are we looking for? Eur Respir Rev (2011) 1.73

Lymphangiogenesis in lymphangioleiomyomatosis: its implication in the progression of lymphangioleiomyomatosis. Am J Surg Pathol (2004) 1.67

Doxycycline use in patients with lymphangioleiomyomatosis: safety and efficacy in metalloproteinase blockade. J Bras Pneumol (2011) 1.55

Effects of rapamycin on angiomyolipomas in patients with tuberous sclerosis. Nefrologia (2011) 1.53

Multicenter phase 2 trial of sirolimus for tuberous sclerosis: kidney angiomyolipomas and other tumors regress and VEGF- D levels decrease. PLoS One (2011) 1.48

Molecular pathogenesis of lymphangioleiomyomatosis: lessons learned from orphans. Am J Respir Cell Mol Biol (2006) 1.47

Doxycycline treatment for lymphangioleiomyomatosis with urinary monitoring for MMPs. N Engl J Med (2006) 1.42

Markers of cell proliferation and expression of melanosomal antigen in lymphangioleiomyomatosis. Am J Respir Cell Mol Biol (1999) 1.37

Exacerbation of pulmonary lymphangioleiomyomatosis by exogenous oestrogen used for infertility treatment. Thorax (2002) 1.29

Lymphangioleiomyomatosis: new concepts in pathogenesis, diagnosis, and treatment. Semin Respir Crit Care Med (2012) 1.20

Pulmonary lymphangioleiomyomatosis in a man. Am J Respir Crit Care Med (2000) 1.20

Effect of doxycycline on proliferation, MMP production, and adhesion in LAM-related cells. Am J Physiol Lung Cell Mol Physiol (2010) 1.06

Lung transplantation for lymphangioleiomyomatosis: the European experience. J Heart Lung Transplant (2009) 1.03

Mammalian target of rapamycin signaling and autophagy: roles in lymphangioleiomyomatosis therapy. Proc Am Thorac Soc (2010) 0.99

Pulmonary lymphangioleiomyomatosis. Arch Pathol Lab Med (2010) 0.96

Pulmonary lymphangioleiomyomatosis and multiple hepatic angiomyolipomas in a man. Pathol Int (2003) 0.93

Current management of lymphangioleiomyomatosis. Curr Opin Pulm Med (2011) 0.92

Clinical utility of diagnostic guidelines and putative biomarkers in lymphangioleiomyomatosis. Respir Res (2012) 0.92

The role of vascular endothelial growth factor-D in diagnosis of lymphangioleiomyomatosis (LAM). Respir Med (2012) 0.92

Lymphatics in lymphangioleiomyomatosis and idiopathic pulmonary fibrosis. Eur Respir Rev (2012) 0.90

Is sirolimus a therapeutic option for patients with progressive pulmonary lymphangioleiomyomatosis? Respir Res (2011) 0.89

[Lymphangioleiomyomatosis: new therapeutic approaches]. Arch Bronconeumol (2011) 0.89

Real-time monitoring of tumorigenesis, dissemination, & drug response in a preclinical model of lymphangioleiomyomatosis/tuberous sclerosis complex. PLoS One (2012) 0.87

Milestones in lymphangioleiomyomatosis research. Eur Respir Rev (2011) 0.84

Lymphangioleiomyomatosis. Arch Bronconeumol (2011) 0.84

Lymphangioleiomyomatosis treatment with sirolimus. Arch Bronconeumol (2011) 0.82

Therapeutic options for lymphangioleiomyomatosis (LAM): where we are and where we are going. F1000 Med Rep (2009) 0.79

Quantitative CT analysis of small pulmonary vessels in lymphangioleiomyomatosis. Eur J Radiol (2012) 0.79

Efficacy of hormonal suppression in a patient with chyluria due to lymphangioleiomyomatosis. Multidiscip Respir Med (2011) 0.78

Progress in the treatment of lymphangioleiomyomatosis: from bench to bedside. Rev Port Pneumol (2012) 0.76

Articles by these authors

Functional involvement of Tudor and dPRMT5 in the piRNA processing pathway in Drosophila germlines. EMBO J (2009) 1.94

Catamenial pneumothorax: a rare entity? Report of 5 cases and review of the literature. J Thorac Dis (2012) 1.63

Effect of CPAP treatment on endothelial function and plasma CRP levels in patients with sleep apnea. Med Sci Monit (2012) 1.61

Myocardial mechanics for the early detection of cardiac sarcoidosis. Int J Cardiol (2013) 1.57

How common is sleep-disordered breathing in patients with idiopathic pulmonary fibrosis? Sleep Breath (2010) 1.57

Extrapelvic endometriosis: a rare entity or an under diagnosed condition? Diagn Pathol (2013) 1.49

Treatment of non-small cell lung cancer (NSCLC). J Thorac Dis (2013) 1.49

Successful application of extracorporeal membrane oxygenation due to pulmonary hemorrhage secondary to granulomatosis with polyangiitis. Drug Des Devel Ther (2013) 1.37

Molecular Targeted Drugs and Biomarkers in NSCLC, the Evolving Role of Individualized Therapy. J Cancer (2013) 1.31

Difficult airway and difficult intubation in postintubation tracheal stenosis: a case report and literature review. Ther Clin Risk Manag (2012) 1.18

Inhaled chemotherapy in lung cancer: future concept of nanomedicine. Int J Nanomedicine (2012) 1.18

Application of flexible bronchoscopy in inhalation lung injury. Diagn Pathol (2013) 1.15

Endometriosis of the lung: report of a case and literature review. Eur J Med Res (2013) 1.15

Clinical experimentation with aerosol antibiotics: current and future methods of administration. Drug Des Devel Ther (2013) 1.14

Effete-mediated degradation of Cyclin A is essential for the maintenance of germline stem cells in Drosophila. Development (2009) 1.10

Intensive care unit and lung cancer: when should we intubate? J Thorac Dis (2013) 1.10

Malignant pleural effusion and algorithm management. J Thorac Dis (2013) 1.09

MDM2 E3 ubiquitin ligase mediates UT-A1 urea transporter ubiquitination and degradation. Am J Physiol Renal Physiol (2008) 1.08

Biogenesis pathways of piRNAs loaded onto AGO3 in the Drosophila testis. RNA (2010) 1.08

An interview between a pulmonologist and a thoracic surgeon-Pleuroscopy: the reappearance of an old definition. J Thorac Dis (2013) 1.06

Otefin, a nuclear membrane protein, determines the fate of germline stem cells in Drosophila via interaction with Smad complexes. Dev Cell (2008) 1.06

Therapeutic procedure in small cell lung cancer. J Thorac Dis (2013) 1.06

Docetaxel-carboplatin in combination with erlotinib and/or bevacizumab in patients with non-small cell lung cancer. Onco Targets Ther (2013) 1.04

Lung ossification: an orphan disease. J Thorac Dis (2013) 1.03

Video assisted thoracoscopic plication of the left hemidiaphragm in symptomatic eventration in adulthood. J Thorac Dis (2012) 1.01

Interleukin-8 and interleukin-17 for cancer. Cancer Invest (2014) 1.00

Pelvic schwannoma in the right parametrium. Int J Gen Med (2013) 1.00

Resection of a giant bilateral retrovascular intrathoracic goiter causing severe upper airway obstruction, 2 years after subtotal thyroidectomy: a case report and review of the literature. J Thorac Dis (2012) 0.99

Williams-Campbell syndrome: a case report. Int J Gen Med (2012) 0.97

Adjuvant chemotherapy and radiotherapy in the treatment of non-small cell lung cancer (NSCLC). J Thorac Dis (2013) 0.96

Interleukin-6 cytokine: a multifunctional glycoprotein for cancer. Immunome Res (2013) 0.95

Immunomodifiers in combination with conventional chemotherapy in small cell lung cancer: a phase II, randomized study. Drug Des Devel Ther (2013) 0.94

Caveolin-1 directly interacts with UT-A1 urea transporter: the role of caveolae/lipid rafts in UT-A1 regulation at the cell membrane. Am J Physiol Renal Physiol (2009) 0.94

Abdominal wall endometrioma mimicking an incarcerated hernia: a case report. Int J Gen Med (2012) 0.94

Glomus tumor in the lung parenchyma. J Thorac Dis (2012) 0.94

Optimizing endobronchial ultrasound for molecular analysis. How many passes are needed? Ann Am Thorac Soc (2013) 0.92

Lung cancer surgery: an up to date. J Thorac Dis (2013) 0.92

Health costs from hospitalization with H1N1 infection during the 2009-2010 influenza pandemic compared with non-H1N1 respiratory infections. Int J Gen Med (2012) 0.92

Moxifloxacin in multidrug-resistant tuberculosis: is there any indication for therapeutic drug monitoring? Eur Respir J (2012) 0.91

Malignant pleural mesothelioma: current and future perspectives. J Thorac Dis (2013) 0.91